Publicacions en col·laboració amb investigadors/es de Karolinska Institute (9)

2023

  1. SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease

    Journal of Neuroimmune Pharmacology, Vol. 18, Núm. 3, pp. 529-550

2018

  1. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

2017

  1. GPR55: A therapeutic target for Parkinson's disease?

    Neuropharmacology, Vol. 125, pp. 319-332

  2. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 4, pp. 991-1001

2015

  1. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

  2. Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

    Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482

2011

  1. Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF down regulation

    Hippocampus, Vol. 21, Núm. 9, pp. 999-1009

2010

  1. HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 3, pp. 829-838

  2. Insulin levels are decreased in the cerebrospinal fluid of women with prodomal alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 2, pp. 405-413